Why the study?
Does cardiac resynchronization therapy reduce all-cause mortality in patients with drug refractory moderate-to-severe heart failure compared to optimal pharmacological therapy?
Does cardiac resynchronization therapy reduce all-cause mortality in patients with drug refractory moderate-to-severe heart failure compared to optimal pharmacological therapy?
No takes yet. Share an insight, caveat, or question.
This editorial highlights that cardiac resynchronization therapy significantly reduces all-cause mortality in chronic heart failure, though its specific impact on sudden cardiac death may require longer-term follow-up to fully manifest.
Frieder Braunschweig (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: